Senior Pre-clinical Advisor

Andrew is a registered toxicologist and has almost 40 years of scientific experience within pre-clinical drug development, specifically programme and study design, data Interpretation, input to regulatory submissions or meetings and advice with CRO selection within pharmacology and toxicology.

Before going into consultancy, Andrew gained his experience working for international CRO’s – both Huntingdon Life Sciences in UK and Scantox, Citoxlab in Denmark – both in different managerial positions but also in supporting clients directly.

With his experience in design and management of pre-clinical drug development and with his understanding of both small biotech and larger pharma company priorities, he is ideally skilled to provide expert advice to clients.